Title: Effects of the new dual PPAR α/δ agonist GFT505 on lipid and glucose homeostasis in abdominally obese patients with combined dyslipidemia or impaired glucose metabolism.
Journal: Diabetes care 20110901
765948-99-0 | 4-Bromo-7-nitroisoindolin-1-one | AA00G84U | MFCD18432551
81245-27-4 | 4-Iodo-3-(methoxymethoxy)pyridine | AA00G8NM | MFCD27929136
815588-82-0 | 1-Methyl-1h-1,2,4-triazole-3-carboxylic acid | AA00G9F9 | MFCD18072681
852212-51-2 | 3-[(3-Fluorophenyl)carbonyl]piperidine HCl | AA00G9K3 | MFCD11846284
75180-45-9 | (1-(4-Methoxyphenyl)cyclopropyl)methanamine | AA00G9ST | MFCD06213249
856562-96-4 | (R)-1-(4-Bromophenyl)propan-1-amine hydrochloride | AA00GA6V | MFCD12910477
850085-99-3 | 5-Amino-2-isopropylphenol | AA00GAMD | MFCD16997161
794566-79-3 | 3-(Cyclopentylmethyl)isoxazol-5-amine | AA00GFFE | MFCD10689548
786684-00-2 | 2-[(Oxan-4-yl)amino]ethan-1-ol | AA00GIFP | MFCD11849403
849351-92-4 | 1,2-Dimethyl-1h-imidazole-5-sulphonyl chloride | AA00GLRT | MFCD03094627